KAO, LI LING,高丽玲,高麗玲,SU, FANG YI,苏芳义,蘇芳義,LU, WEN JEN,吕文仁,呂文仁
申请号：
TW108128142
公开号：
TW202014180A
申请日:
2019.08.07
申请国别(地区):
TW
年份:
2020
代理人:
摘要：
The present invention relates to a solid formulation including celecoxib and method for manufacturing the same. Based on a total mass of the solid formulation as 100 mass %, the solid formulation is characterized by 1 mass % to 15 mass % of a surfactant and 1 mass % to 5 mass % of a binder without disintegrants therein. Moreover, the method for manufacturing the solid formulation including celecoxib is characterized that the solid formulation is made by wet granulation method.本發明有關於一種含有希樂葆(Celecoxib)的固體製劑及其製造方法。前述含有希樂葆的固體製劑之特徵在於，以固體製劑的總質量為100質量%，固體製劑1質量%至15質量%之界面活性劑及1質量%至5質量%之黏合劑且不含崩散劑。其次，本發明之含有希樂葆的固體製劑的製造方法，其特徵在於利用濕式造粒法製造前述含有希樂葆的固體製劑。
